세계 흉막 질환 시장 : 질환 유형별, 진단 툴별, 치료 수단별, 최종 사용자별, 지역별

Pleural Diseases Market, By Disease Type, By Diagnostic Tools, By Treatment Modalities, By End User, By Geography

US $ 4,500 ￦ 6,286,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,000 ￦ 9,778,000

PDF (Multi User License)

PDF 보고서를 동일 사업장에서 7명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 13,969,000

PDF (Enterprise User License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계 흉막질환 시장 규모는 2023년 50억 1,000만 달러로 평가되었으며 2023년부터 2030년까지 복합 연간 성장률(CAGR) 7.2%를 나타낼 전망이며 2030년에는 81억 3,000만 달러에 이를 것으로 예측됩니다.

보고 범위		보고서 세부정보
기준년	2022년	2023년 시장 규모	50억 1,000만 달러
업적 데이터	2018년-2021년	예측 기간	2023-2030
예측 기간의 복합 연간 성장률(CAGR)	7.20%	2030년 시장 규모 예측	81억 3,000만 달러

흉막 질환은 폐를 둘러싸는 얇은 막인 흉막에 영향을 미치는 다양한 질병군을 포함합니다. 이 질병은 호흡 기능과 전신 건강에 큰 영향을 줄 수 있습니다. 흉막은 윤활을 제공하고 호흡 중 부드러운 움직임을 허용함으로써 폐의 구조와 기능의 무결성을 유지하는 데 중요한 역할을합니다. 흉막 질환은 감염, 염증, 종양, 유해 물질에 대한 노출과 같은 다양한 원인으로 인해 발생할 수 있습니다. 일반적인 흉막 질환에는 흉막염, 흉수, 기흉, 중피종 등이 있습니다. 증상을 인식하고 정확하게 진단하고 적절한 치료 전략을 시행하는 것은 이러한 과제인 세계 흉막 질환을 앓고 있는 환자를 관리하고 결과를 개선하는 데 필수적입니다. 세계 흉막질환 시장은 흡연, 결핵, 전이 등 관련 위험 인자의 유병률 상승에 견인되어 오랫동안 꾸준히 성장하고 있습니다. 게다가 영상 진단 기술이나 레이저 치료 등의 진단 및 치료 방법에 있어서의 현저한 기술 진보가 시장의 성장을 더욱 뒷받침하고 있습니다.

시장 역학:

합의와 같은 무기적 전략의 채택이 증가하고 있는 것도 예측 기간 동안 시장 성장을 가속할 것으로 예상됩니다. 예를 들어, 2020년 11월, 제약회사인 오펭약품산업주식회사와 임상단계의 바이오의약품회사인 Lung Therapeutics, Inc. 미노겐 활성화 인자 LTI-01의 한국성 흉수에 대한 일본 영역에서의 독점적 라이선스 계약을 발표했습니다.

그러나 낮은 인지도와 진단 지연, 진단 도구 및 치료 비용, 전문 지식 및 자원 부족 등이 예측 기간 동안 세계 흉막 질환 시장의 성장을 방해할 것으로 예상됩니다.

본 조사의 주요 특징

• 본 보고서는 세계 흉막 질환 시장을 상세하게 분석하여 2022년을 기준년으로 한 예측기간(2023년-2030년) 시장 규모 및 복합 연간 성장률(CAGR)을 제공합니다.
• 또한 다양한 부문에 걸친 잠재적인 수익 기회를 밝히고, 이 시장에 대한 매력적인 투자 제안의 행렬을 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시와 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 주요 고찰도 제공합니다.
• 엔터프라이즈 하이라이트, 제품 포트폴리오, 주요 하이라이트, 성과, 전략 등의 매개변수를 기반으로 세계 흉막 질환 시장의 주요 기업을 프로파일링합니다.
• 이 보고서의 인사이트을 통해 마케팅 담당자와 기업 경영진이 향후 제품 출시, 타이핑, 시장 확대, 마케팅 전술에 대한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
• 세계 흉막질환 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 지원합니다.
• 이해관계자들은 세계 흉막질환 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.

목차

제1장 조사의 목적과 전제

• 조사 목적
• 가정
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 성장 촉진요인
• 호흡기 질환의 이환율 증가
  • 억제요인
• 이용할 수 있는 전문 지식과 자원이 한정되어 있다
  • 기회
• 신흥 바이오 마커와 정밀의료
• 영향 분석
• 주요 하이라이트
• 규제 시나리오
• 제품 출시/승인
• PEST 분석
• Porter's Five Forces 분석
• 합병과 인수 시나리오

제4장 세계 흉막질환 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• 신형 코로나 바이러스 감염증(COVID-19)의 역학
• 공급측과 수요측 분석
• 경제적 영향

제5장 세계 흉막질환 시장 : 질환 유형별(2018년-2030년)

• 소개
• 흉막염
• 흉수
• 폐피종
• 중피종
• 기타

제6장 세계 흉막질환 시장 : 진단 툴별(2018년-2030년)

• 소개
• 이미징 기술
• 분자진단학
• 흉강경 검사와 흉막경 검사

제7장 세계 흉막 질환 시장 : 치료 수단별(2018년-2030년)

• 소개
• 약
• 흉강 천자와 흉막 유착술
• 저침습 개입
• 외과적 개입

제8장 세계 흉막질환 시장 : 최종 사용자별(2018년-2030년)

• 소개
• 병원 및 진료소
• 진단센터
• 연구 및 학술기관

제9장 세계 흉막질환 시장 : 지역별(2018년-2030년)

• 소개
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동
• 아프리카

제10장 경쟁 구도

• Bristol Myers Squibb
• Merck & Co., Inc.
• GlaxoSmithKline plc
• Boehringer Ingelheim International GmbH
• Sanofi
• AbbVie Inc.
• Braun SE
• Becton, Dickinson and Company
• Bicakcilar
• Biometrix
• Cook Medical
• Grena
• Redax
• Rocket Medical
• Smith Medical

제11장 섹션

• 조사 방법
• 출판사에 대해

BJH

영문 목차

영문목차

The Global Pleural Diseases Market size was valued at US$ 5.01 Bn in 2023 and is expected to reach US$ 8.13 Bn by 2030, growing at a compound annual growth rate (CAGR) of 7.2% from 2023 to 2030.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 5.01 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	7.20%	2030 Value Projection:	US$ 8.13 Bn

Pleural diseases encompass a diverse group of conditions affecting the pleura, the thin membrane surrounding the lungs. These conditions can significantly impact respiratory function and overall well-being. The pleura plays a crucial role in maintaining the integrity of the lung's structure and function by providing lubrication and allowing smooth movement during breathing. Pleural diseases can arise from various causes, including infections, inflammation, tumors, and exposure to hazardous substances. Common pleural disorders include pleurisy, pleural effusion, pneumothorax and mesothelioma. Recognizing the symptoms, diagnosing accurately, and implementing appropriate treatment strategies are essential in managing and improving outcomes for individuals affected by these challenging global pleural diseases. The global global pleural diseases market has been steadily growing over the years driven by the rising prevalence of associated risk factors such as smoking, tuberculosis, and metastases. Furthermore, the market has witnessed significant technological advancements in diagnosis and treatment modalities such as imaging techniques and laser therapy, further supporting the market growth.

Market Dynamics:

The increasing adoption of inorganic strategies such as agreement is also expected to drive the growth of the market over the forecast period. For instance, in November 2020, Taiho Pharmaceutical Co., Ltd, a pharmaceutical company, and Lung Therapeutics, Inc., a clinical-stage biopharmaceutical company, announced an exclusive license agreement of LTI-01, a recombinant human single-chain urokinase plasminogen activator, currently under development by Lung Tx for loculated pleural effusions, for the territory of Japan.

However, limited awareness and delayed diagnosis, cost of diagnostic tools and treatment, limited availability of expertise and resources are expected to hamper growth of the global pleural diseases market over the forecast period.

Key features of the study:

• This report provides an in-depth analysis of the global pleural diseases market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the Global Pleural Diseases market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Bristol Myers Squibb, Merck & Co., Inc., GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Sanofi, AbbVie Inc., B. Braun SE, Becton, Dickinson and Company, Bicakcilar, Biometrix, Cook Medical, Grena, Redax, Rocket Medical, Smith Medical.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global pleural diseases market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pleural diseases market

Global Pleural Diseases Market Segmentation Detailed Segmentation:

• By Disease Types:
  • Pleurisy
  • Pleural Effusion
  • Pneumothelioma
  • Mesothelioma
  • Others
• By Diagnostic Tools:
  • Imaging Techniques
  • Molecular Diagnostics
  • Thoracoscopy and Pleuroscopy
• By Treatment Modalities:
  • Medications
  • Thoracentesis and Pleurodesis
  • Minimally Invasive Interventions
  • Surgical Interventions
• By End User:
  • Hospitals and Clinics
  • Diagnostic Centers
  • Research and Academic Institutions
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profile:
  • Bristol Myers Squibb
  • Merck & Co., Inc.
  • GlaxoSmithKline plc
  • Boehringer Ingelheim International GmbH
  • Sanofi
  • AbbVie Inc.
  • Braun SE
  • Becton, Dickinson and Company
  • Bicakcilar
  • Biometrix
  • Cook Medical
  • Grena
  • Redax
  • Rocket Medical
  • Smith Medical

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Pleural Diseases, By Disease Type
  • Market Pleural Diseases, By Diagnostic Tools
  • Market Pleural Diseases, By Treatment Modalities
  • Market Pleural Diseases, By End User
  • Market Pleural Diseases, By Geography/Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Increasing Prevalence of Respiratory diseases
  • Restraints
• Limited Availability of Expertise and Resources
  • Opportunities
• Emerging Biomarkers and Precision Medicine
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Pleural Diseases Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Pleural Diseases Market, By Disease Type, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Pleurisy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Pleural Effusion
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Pneumothelioma
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Mesothelioma
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Pleural Diseases Market, By Diagnostic Tools, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Imaging Techniques
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
• Molecular Diagnostics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 20218-2030, (US$ Billion)
• Thoracoscopy and Pleuroscopy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

7. Global Pleural Diseases Market, By Treatment Modalities, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Medications
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
• Thoracentesis and Pleurodesis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
• Minimally Invasive Interventions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
• Surgical Interventions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

8. Global Pleural Diseases Market, By End User, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Hospitals and Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
• Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
• Research and Academic Institutions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

9. Global Pleural Diseases Market, By Region, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, By Country, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Country 2019 -2030
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)

10. Competitive Landscape

• Bristol Myers Squibb
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck & Co., Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• GlaxoSmithKline plc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Boehringer Ingelheim International GmbH
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Sanofi
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• AbbVie Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Braun SE
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Becton, Dickinson and Company
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Bicakcilar
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Biometrix
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Cook Medical
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Grena
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Redax
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Rocket Medical
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Smith Medical
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

11. Section

• Research Methodology
• About us

관련자료